Logo for Personalis Inc

Personalis Investor Relations Material

Latest events

Logo for Personalis Inc

Q1 2024

Personalis
Logo for Personalis

Q1 2024

8 May, 2024
Logo for Personalis

Q4 2023

28 Feb, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies

Latest reports from Personalis Inc

Access all reports
Segment Data
Access more data
Revenue by
Customer type
Pharma tests and services
Enterprise sales
Population sequencing
Other
Expenses by
Financials
Personalis Cancer Genome Tests allow physicians to classify patients' tumors based on shared genomic changes and match them with therapies known to be effective for those alterations, such as targeted therapies, immunotherapies, or clinical trials. Its software solutions include ACE Clinical that provides clinical researchers with data-driven insights into biomarkers and biologic drug mechanisms; ACE Biology that interprets human genome information to allow researchers to gain insight into potential oncology drug targets and underlying mechanisms of drug resistance; and Product Management platform that allows customers to order personalized tests. The company was formerly known as Illumina TRUseq Custom Amplicon and changed its name to Personalis, Inc. in May 2013. Personalis, Inc. was founded in 2012 and is headquartered in Menlo Park, California.